Schedule 13G ownership disclosure

ACHILLION PHARMACEUTICALS INC

Security class unavailable · CUSIP: 00448Q201

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,868,981
Percent of class
2.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000769993-16-001380
Form type
SC 13G/A
Filer
ACHILLION PHARMACEUTICALS INC
CIK
CIK 1070336
Filed
Feb 10, 2016
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub